Zhengjia Chen
机构: Univeristy of Illinois at Chicago
每年引用次数
引用次数
引用: 12,663
H-指数: 65
I10-指数 : 188
出版物: 389
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.
Adeboye O Osunkoya , Rianot Amzat , Bital Savir-Baruch , Baowei Fei
American journal of nuclear medicine and molecular imaging 3 ( 1) 85 -96
60
2013
Methodology and Application of Adaptive and Sequential Approaches
Zhengjia Chen , Ye Cui , Jeanne Kowalski , Yichuan Zhao
2012
Reproducibility of anti-3-[18F]FACBC uptake in background structures and malignant lesions on followup PET-CT in prostate carcinoma: An exploratory analysis
Bital Savir-Baruch , Oluwaseun Odewole , Viraj Master , Raghuveer Halkar
Society of Nuclear Medicine Annual Meeting Abstracts 55 1668
2014
Surveillance Imaging during First-Remission in Follicular Lymphoma Does Not Impact Overall Survival
Zhengjia Chen , Jonathon B Cohen , Christopher Flowers , Oscar Calzada
Blood 130 1501 -1501
6
2017
[18F]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
Mehrdad Alemozaffar , Viraj Master , Akinyemi Akintayo , Joseph Shelton
The Journal of Nuclear Medicine 60 1576 -1576
2019
High-Risk FLIPI Score at Diagnosis Is Associated with Early Relapse in the Rituximab Era for Patients with Follicular Lymphoma
Zhengjia Chen , Jonathon B Cohen , Christopher Flowers , Oscar Calzada
Blood 130 5158 -5158
2017
Quantitative analysis of pre- and post-treatment PET-CT scans using deformable image registration methods.
Eduard Schreibmann , Ian Crocker , Jerome C Landry , Timothy H Fox
Journal of radiosurgery and SBRT 2 ( 1) 51 -62
2012
18F-fluciclovine PET/CT findings are predictive of failure-free survival following salvage radiotherapy in post-prostatectomy patients with biochemical recurrence.
Mehrdad Alemozaffar , Viraj Master , Akinyemi Akintayo , Joseph Shelton
The Journal of Nuclear Medicine 61 1245 -1245
1
2020
Signaling and Targeting of Glutamate Dehydrogenase 1 in Metastatic Non-Small Cell Lung Carcinoma
Sumin Kang , Taofeek K Owonikoko , Kelly R Magliocca , Zhengjia Chen
2018
Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
Sreenivas Nannapaneni , Christopher C Griffith , Kelly R Magliocca , Wanqi Chen
PLOS ONE 16 ( 2)
5
2021
Mismatch Repair (MMR) gene alteration and BRAF V600E mutation are potential predictive biomarkers of immune checkpoint inhibitors in MMR-deficient colorectal cancer
Gregory B. Lesinski , Sigurdis Haraldsdottir , Bassel F. El‐Rayes , Zhengjia Chen
Oncologist
2021
Results of Interim PET/CT Imaging during Front-Line Induction in Follicular Lymphoma Do Not Predict Survival Outcomes
Zhengjia Chen , Jonathon B Cohen , Christopher Flowers , Oscar Calzada
Blood 130 5156 -5156
2017
Survival Outcomes of Acinar Cell Pancreatic Cancer: A National Cancer Database Analysis.
Mehmet Akce , Bassel F El-Rayes , Walid L Shaib , Christina Wu
Pancreas 50 ( 4) 529 -536
2021
Safety of intranasal ketamine for reducing uncontrolled cancer-related pain: Protocol of a phase i/II clinical trial
Jack W Shteamer , R Donald Harvey , Boris Spektor , Kimberly Curseen
JMIR 21 ( 4)
2019
Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information
Michael Kutner , Zhengjia Chen , Zhengjia Chen , Yuzi Zhang
Biometrical Journal
2021
Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information
Michael Kutner , Zhengjia Chen , Zhengjia Chen , Yuzi Zhang
Biometrical Journal
2021
Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity
Debatosh Majumdar , Kyung-Ho Jung , Hongzheng Zhang , Sreenivas Nannapaneni
Cancer Prevention Research 7 ( 1) 65 -73
76
2014
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
Nabil F Saba , Selwyn J Hurwitz , Scott A Kono , Chung S Yang
Cancer Prevention Research 7 ( 3) 283 -291
48
2014
Phase IB study of induction chemotherapy with XELOX, followed by radiation therapy, carboplatin, and everolimus in patients with locally advanced esophageal cancer (EC).
Nabil F. Saba , Seth D Force , Charles A. Staley , Felix G Fernandez
Journal of Clinical Oncology 35
2017
Collection and utilization of oncology big data.
Shubham Pant , Taofeek Kunle Owonikoko , Catherine S. Magid Diefenbach , Sungjin Kim
Journal of Clinical Oncology 35
2017